Luc Buee

USPTO Granted Patents = 7 (Patent Applications = 6)

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 5(Granted Patents)

Location History:

Templemars, FR (2013 - 2020)
Lille, FR (2018 - 2020)

Company Filing History:

6 out of 1,743

Institut National De La Sante Et De La Recherche Medicale

Université De Lille 2 Droit Et Santé

Universite De Lille 2 Droit Et Saute

patent

7. 1 out of 9

Centre Hospitalier Regional Et Universitaire De Lille (chru)

patents

8. 1 out of 1

Universite Du Droit Et De La Santa-lille Ii

patent

where one patent can have more than one assignee

Years Active: 2013-2020

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10807958 - 1,4-bis(3-aminopropyl)piperazine derivative and its use (2020-10-20),

2. 10772884 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2020-09-15),

3. 10537569 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2020-01-21),

4. 10017476 - 1,4-bis(3-aminopropyl)piperazine derivative and its use (2018-07-10),

5. 9562018 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2017-02-07),

6. 9044478 - Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases (2015-06-02),

7. 8343493 - Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs (2013-01-01),

Title: Luc Buee: Innovator in Neurodegenerative Disease Research

Introduction

Luc Buee is a prominent inventor based in Templemars, France. He has made significant contributions to the field of neurodegenerative diseases, holding a total of seven patents. His work focuses on developing compounds that can potentially treat and prevent various tauopathies.

Latest Patents

Among his latest patents is the invention of a compound known as 1,4-bis(3-aminopropyl)piperazine derivative. This compound is described as having the potential to treat and/or prevent tauopathies. Another notable patent involves the sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine. This invention includes the preparation of these salts and their use in pharmaceutical compositions aimed at treating neurodegenerative diseases.

Career Highlights

Luc Buee has worked with esteemed organizations such as the National Institute of Health and Medical Research (Institut National De La Sante Et De La Recherche Medicale) and Alzprotect. His career reflects a strong commitment to advancing medical research and innovation.

Collaborations

Throughout his career, Luc has collaborated with notable colleagues, including Nicolas Sergeant and Patricia Melnyk. These partnerships have contributed to the development of his innovative research and patents.

Conclusion

Luc Buee's work in the field of neurodegenerative diseases showcases his dedication to innovation and research. His patents reflect a significant impact on potential treatments for these challenging conditions.

This text is generated by artificial intelligence and may not be accurate.